Feasibility of Conducting a Trial Assessing Benefits and Risks of Planned Caesarean Section Versus Planned Vaginal Birth: A Cross-Sectional Study.
Adolescent
Adult
Argentina
Cesarean Section
/ statistics & numerical data
Cohort Studies
Cross-Sectional Studies
Delivery, Obstetric
/ methods
Elective Surgical Procedures
Feasibility Studies
Female
Health Personnel
/ psychology
Humans
Male
Middle Aged
Patient Preference
Pregnancy
Risk Assessment
Young Adult
Elective cesarean delivery
Partially randomized patient preference trial
Preference controlled trial
Randomized controlled trial
Vaginal delivery
Journal
Maternal and child health journal
ISSN: 1573-6628
Titre abrégé: Matern Child Health J
Pays: United States
ID NLM: 9715672
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
accepted:
07
11
2020
pubmed:
5
1
2021
medline:
13
8
2021
entrez:
4
1
2021
Statut:
ppublish
Résumé
Though interest is growing for trials comparing planned delivery mode (vaginal delivery [VD]; cesarean section [CS]) in low-risk nulliparous women, appropriate study design is unclear. Our objective was to assess feasibility of three designs (preference trial [PCT], randomized controlled trial [RCT], partially randomized patient preference trial [PRPPT]) for a trial comparing planned delivery mode in low-risk women. A cross-sectional survey of low-risk, nulliparous pregnant women (N = 416) and healthcare providers (N = 168) providing prenatal care and/or labor/delivery services was conducted in Argentina (2 public, 2 private hospitals). Proportion of pregnant women and providers willing to participate in each design and reasons for not participating were determined. Few women (< 15%) or professionals (33.3%) would participate in an RCT, though more would participate in PCTs (88% women; 65.9% professionals) or PRPPTs (44.4% public, 63.4% private sector women; 44.0% professionals). However, most women would choose vaginal delivery in the PCT and PRPPT (> 85%). Believing randomization unacceptable (RCT, PRPPT) and desiring choice of delivery mode (RCT) were women's reasons for not participating. For providers, commonly cited reasons for not participating included unacceptability of performing CS without medical indication, difficulty obtaining informed consent, discomfort enrolling patients (all designs), and violating women's right to choose (RCT). Important limitations were found for each trial design evaluated. The necessity of stronger evidence regarding delivery mode in low-risk women suggests consideration of additional designs, such as a rigorously designed cohort study or an RCT within an obstetric population with equivocal CS indications.
Identifiants
pubmed: 33392930
doi: 10.1007/s10995-020-03073-4
pii: 10.1007/s10995-020-03073-4
pmc: PMC7922524
mid: NIHMS1659504
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
136-150Subventions
Organisme : NICHD NIH HHS
ID : T32 HD057780
Pays : United States
Organisme : FIC NIH HHS
ID : R25 TW009340
Pays : United States
Organisme : FIC NIH HHS
ID : R25TW009340
Pays : United States
Organisme : NIH HHS
ID : 5T32HD057780
Pays : United States
Organisme : Maternal and Child Health Bureau
ID : T03MC07649
Références
J Clin Epidemiol. 2000 Feb;53(2):163-6
pubmed: 10729688
Aust N Z J Obstet Gynaecol. 2008 Dec;48(6):542-6
pubmed: 19133040
Control Clin Trials. 1985 Jun;6(2):120-7
pubmed: 4006485
BMJ. 1989 Jul 29;299(6694):313-5
pubmed: 2504416
N Engl J Med. 2013 Oct 3;369(14):1295-305
pubmed: 24088091
BJOG. 2018 Sep;125(10):1294-1302
pubmed: 29325216
Cochrane Database Syst Rev. 2001;(2):CD000078
pubmed: 11405950
PLoS Med. 2012;9(3):e1001192
pubmed: 22427749
Aust N Z J Obstet Gynaecol. 2004 Dec;44(6):521-4
pubmed: 15598289
Cochrane Database Syst Rev. 2012 Mar 14;(3):CD004660
pubmed: 22419296
BMJ. 2005 Sep 3;331(7515):490-1
pubmed: 16115829
Lancet Glob Health. 2018 Aug;6(8):e894-e901
pubmed: 30012270
BJOG. 2014 Dec;121 Suppl 7:48-53
pubmed: 25488088
Ginecol Obstet Mex. 2012 Apr;80(4):263-9
pubmed: 22808856
Early Hum Dev. 2012 Dec;88(12):943-9
pubmed: 23036493
J Obstet Gynaecol Can. 2018 Jul;40(7):967-971
pubmed: 29921432
JAMA. 2013 May 8;309(18):1930-6
pubmed: 23652524
J Reprod Med. 1984 Oct;29(10):736-40
pubmed: 6512783
PLoS One. 2016 Feb 05;11(2):e0148343
pubmed: 26849801
Reprod Health. 2013 Jan 14;10(1):2
pubmed: 23317141
J Obstet Gynaecol Can. 2004 Jun;26(6):575-9
pubmed: 15193203
J Obstet Gynaecol. 2018 Apr;38(3):367-371
pubmed: 29374994
Birth. 2016 Dec;43(4):285-292
pubmed: 27321272
Perspect Biol Med. 2013 Winter;56(1):18-35
pubmed: 23748524
Lancet. 2000 Oct 21;356(9239):1375-83
pubmed: 11052579
Am J Obstet Gynecol. 1996 Apr;174(4):1393-4
pubmed: 8623877
BJOG. 2016 Apr;123(5):667-70
pubmed: 26681211
BMC Pregnancy Childbirth. 2016 Feb 08;16:34
pubmed: 26857448
Birth. 2009 Sep;36(3):213-9
pubmed: 19747268
Am J Obstet Gynecol. 2009 Sep;201(3):308.e1-8
pubmed: 19733283
Br J Obstet Gynaecol. 1997 Dec;104(12):1367-73
pubmed: 9422014